Your browser doesn't support javascript.
loading
Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2.
Fintzi, Jonathan; Bonnett, Tyler; Tebas, Pablo; Marconi, Vincent C; Levine, Corri B; El Sahly, Hana M; McLellan, Susan L F; Benson, Constance A; Rostad, Christina A; Ganesan, Anuradha; Huprikar, Nikhil; Frank, Maria G; Mularski, Richard A; Atmar, Robert L; Park, Pauline K; Short, William R; Beigel, John H; Mehta, Aneesh K; Sweeney, Daniel A.
Affiliation
  • Fintzi J; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.
  • Bonnett T; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
  • Tebas P; Division of Infectious Diseases/Clinical Trials Unit, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Marconi VC; Emory University School of Medicine and Rollins School of Public Health, Emory Vaccine Center, Atlanta Veterans Affairs Medical Center, Atlanta, Georgia, USA.
  • Levine CB; Division of Infectious Disease, Department of Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
  • El Sahly HM; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
  • McLellan SLF; Division of Infectious Disease, Department of Medicine, University of Texas Medical Branch, Galveston, Texas, USA.
  • Benson CA; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, California, USA.
  • Rostad CA; Division of Infectious Diseases, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Ganesan A; Division of Infectious Disease, Walter Reed National Military Medical Center, Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
  • Huprikar N; Division of Pulmonary/Critical Care Medicine, Walter Reed National Military Medical Center, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
  • Frank MG; Department of Medicine, Denver Health Hospital Authority, Associate Professor of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Mularski RA; The Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
  • Atmar RL; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Park PK; Division of Acute Care Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.
  • Short WR; Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Beigel JH; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.
  • Mehta AK; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Sweeney DA; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of California, San Diego, La Jolla, California, USA.
Open Forum Infect Dis ; 9(7): ofac219, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35818363

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: Open Forum Infect Dis Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: Open Forum Infect Dis Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States